21 CFR Part 530
PART 530—EXTRALABEL DRUG USE IN ANIMALS
- PART 530—EXTRALABEL DRUG USE IN ANIMALS
- Chapter I—Food and Drug Administration, Department of Health and Human Services › Subchapter E—Animal Drugs, Feeds, and Related Products
- Subpart A—General Provisions
- § 530.1 Scope.
- § 530.2 Purpose.
- § 530.3 Definitions.
- § 530.4 Advertising and promotion.
- § 530.5 Veterinary records.
- Subpart B—Rules and Provisions for Extralabel Uses of Drugs in Animals
- § 530.10 Provision permitting extralabel use of animal drugs.
- § 530.11 Limitations.
- § 530.12 Labeling.
- § 530.13 Extralabel use from compounding of approved new animal and approved human drugs.
- Subpart C—Specific Provisions Relating to Extralabel Use of Animal and Human Drugs in Food-Producing Animals
- § 530.20 Conditions for permitted extralabel animal and human drug use in food-producing animals.
- § 530.21 Prohibitions for food-producing animals.
- § 530.22 Safe levels and analytical methods for food-producing animals.
- § 530.23 Procedure for setting and announcing safe levels.
- § 530.24 Procedure for announcing analytical methods for drug residue quantification.
- § 530.25 Orders prohibiting extralabel uses for drugs in food-producing animals.
- Subpart D—Extralabel Use of Human and Animal Drugs in Animals Not Intended for Human Consumption
- § 530.30 Extralabel drug use in nonfood animals.
- Subpart E—Safe Levels for Extralabel Use of Drugs in Animals and Drugs Prohibited From Extralabel Use in Animals
- § 530.40 Safe levels and availability of analytical methods.
- § 530.41 Drugs prohibited for extralabel use in animals.
Feedback